Market News AIOpen the app

COCP stock news · Cocrystal Pharma, Inc.

Stories about Cocrystal Pharma, Inc. (COCP) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for COCP

Follow Cocrystal Pharma, Inc. (COCP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for COCP
Free on the App Store and Google Play, or on the web.
  1. Nov 15, 2026, 9:09 AM ET · Market

    Cocrystal Pharma shared its third quarter 2026 results, noting it finished dosing for its norovirus study.

    Neutral

    Cocrystal finished dosing its last norovirus-study participant. Quarterly research costs rose to $1.978 million from $954,000.